Raffa Wealth Management’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$724 Buy
11
+7
+175% +$545 ﹤0.01% 1102
2026
Q2
$298 Buy
4
+2
+100% +$140 ﹤0.01% 1222
2026
Q1
$149 Buy
+2
New +$145 ﹤0.01% 1224

Other funds holding BBIO

Raffa Wealth Management's BBIO Position: Q3 2026 in Review

Raffa Wealth Management increased its BridgeBio Pharma (BBIO) stake by 175% in Q3 2026, buying an estimated $545 and bringing the position to 11 shares worth $724. The position accounts for ﹤0.01% of the portfolio, ranked #1102.

Raffa Wealth Management first reported a position in BBIO in Q1 2026 and has held it in 3 quarters since. 465 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • Raffa Wealth Management held 11 shares of BridgeBio Pharma worth $724 as of Q3 2026.
  • Raffa Wealth Management bought 7 BridgeBio Pharma shares in Q3 2026, an estimated $545.
  • BridgeBio Pharma made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #1102 holding.
  • Raffa Wealth Management first reported a position in BridgeBio Pharma in Q1 2026 and has held it in 3 quarters since.
  • 465 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.